Arvinas (ARVN) Gains from Investment Securities (2017 - 2018)
Arvinas' (ARVN) quarterly Gains from Investment Securities came in at -$2516.0 in Q2 2018, down 72.68% year-on-year from -$9210.6 in Q2 2017, and down 101.28% quarter-over-quarter from $196295.0 in Q1 2018.
Arvinas (ARVN) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Arvinas' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$2516.0 for Q2 2018.
- On a quarterly basis, Gains from Investment Securities fell 72.68% year-over-year to -$2516.0 in Q2 2018; TTM through Mar 2019 was -$2516.0, a 101.31% decrease from a year earlier, with the FY2018 full-year figure at $193779.0, up 3400.61% from the prior year.
- Gains from Investment Securities fell to -$2516.0 in Q2 2018 per ARVN's latest filing, from $196295.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $196295.0 in Q1 2018 and bottomed at -$2516.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -2,516.00 |
| Jun 30, 2018 | -2,516.00 |
| Mar 31, 2018 | 196,295.00 |
| Mar 31, 2018 | 196,295.00 |
| Dec 31, 2017 | -1,533.00 |
| Dec 31, 2017 | -1,533.00 |
| Sep 30, 2017 | -1,546.00 |
| Sep 30, 2017 | -1,546.00 |
| Jun 30, 2017 | -1,457.00 |
| Jun 30, 2017 | -1,457.00 |
| Mar 31, 2017 | -1,335.00 |
| Mar 31, 2017 | -1,335.00 |